Tianyin Pharmaceutical Co., Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (37)

View All

Latest Posts

About This Stock More About This Stock
Week In Review: Baiyunshan Pharma Raises $1.6 Billion
Article By: ChinaBio® Today
Sunday, January 18, 2015 8:18 PM EDT
Guangzhou Baiyunshan Pharma (HK: 874) will raise $1.6 billion in a secondary offering, which it will use for various corporate initiatives, including expanding its China's online drug selling effort. Yunfeng, the private equity firm co-founded by Alibaba's Jack Ma is an investor.
In this article: BABA, FMI, WX, TPI, BSPM
Read
Week In Review: 2014 Pharma IPOs In China: Just Three
Article By: ChinaBio® Today
Sunday, January 4, 2015 6:43 AM EDT
2014 was supposed to be a breakout year for China life science IPOs. As the year began, China was all set to resume IPOs after a 15-month moratorium, with a new regulatory system and significant pent-up demand.
In this article: WX, TPI
Read
TPI Expects To Receive GMP By End Of 2014; NVIV Reports FDA Approval To Expedite Enrollment For Pilot Trial
Article By: BioMedReports
Wednesday, December 17, 2014 4:27 AM EDT
(TPI) Expects to receive GM, (NVIV) announced approval by the U.S. FDA for an expedited enrollment plan for the company’s ongoing pilot trial of its investigational Neuro-Spinal Scaffold.
In this article: TPI, NVIV
Read
All Posts

Latest Tweets for $TPI

No tweets yet!

PARTNER HEADLINES